US Patent 10039718 | Patents | Expiry | Expiration | Dates

BRISTOL-MYERS SQUIBB

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

ATAZANAVIR SULFATE; COBICISTAT

Supporting Information : Click here to upload a PDF

US Patent Number

10039718

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2032-10-04

Patent Use Code

Delist Requested

Application Number

206353

Patent Use Description

Product Number

1

GILEAD SCIENCES INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

COBICISTAT

Supporting Information : Click here to upload a PDF

US Patent Number

10039718

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2032-10-04

Patent Use Code

Delist Requested

Application Number

203094

Patent Use Description

Product Number

1

GILEAD SCIENCES INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Supporting Information : Click here to upload a PDF

US Patent Number

10039718

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2032-10-04

Patent Use Code

Delist Requested

Application Number

203100

Patent Use Description

Product Number

1

GILEAD SCIENCES INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Supporting Information : Click here to upload a PDF

US Patent Number

10039718

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2032-10-04

Patent Use Code

Delist Requested

Application Number

207561

Patent Use Description

Product Number

1

JANSSEN PRODS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

COBICISTAT; DARUNAVIR

Supporting Information : Click here to upload a PDF

US Patent Number

10039718

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2032-10-04

Patent Use Code

Delist Requested

Application Number

205395

Patent Use Description

Product Number

1

JANSSEN PRODS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Supporting Information : Click here to upload a PDF

US Patent Number

10039718

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2032-10-04

Patent Use Code

Delist Requested

Application Number

210455

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10039718

ATAZANAVIR SULFATE; COBICISTAT

Y

2032-10-04

1

Y

2032-10-04

1

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Y

2032-10-04

1

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Y

2032-10-04

1

COBICISTAT; DARUNAVIR

Y

2032-10-04

1

COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Y

2032-10-04

1